BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4597572)

  • 41. Flupenthixol and the out-patient maintenance treatment of schizophrenia.
    Freeman HL
    Br J Psychiatry; 1973 Jan; 122(566):121-2. PubMed ID: 4683017
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of thiothixene in neurotic reactions.
    Arkonac O; Ergun F
    Dis Nerv Syst; 1969 Jan; 30(1):47-50. PubMed ID: 4887217
    [No Abstract]   [Full Text] [Related]  

  • 43. Trazodone in the treatment of affective disorders.
    Amin M; Ban TA; Klingner A
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):781-8. PubMed ID: 4201976
    [No Abstract]   [Full Text] [Related]  

  • 44. Double-blind comparison of half-dose and standard-dose flupenthixol decanoate in the maintenance treatment of stabilised out-patients with schizophrenia.
    Johnson DA; Ludlow JM; Street K; Taylor RD
    Br J Psychiatry; 1987 Nov; 151():634-8. PubMed ID: 3446307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Placebo-controlled evaluation of phenaglycodol in anxious, depressed outpatients.
    Brauzer B; Goldstein BJ
    J Clin Pharmacol New Drugs; 1972 Jul; 12(7):280-5. PubMed ID: 4557536
    [No Abstract]   [Full Text] [Related]  

  • 46. Clinicl experience with flupenthixol in the treatment of chronic schizophrenia.
    Molcan J; Kukucová H; Koníková M
    Act Nerv Super (Praha); 1971; 13(3):180-1. PubMed ID: 5113828
    [No Abstract]   [Full Text] [Related]  

  • 47. [Value of Déanxit in the ambulatory treatment of depressive states. Clinical study of 205 cases].
    Brasseur R
    Schweiz Rundsch Med Prax; 1972 Sep; 61(37):1153-6. PubMed ID: 4564828
    [No Abstract]   [Full Text] [Related]  

  • 48. Drug defaulting estimated by the use of a drug marker.
    Geisler A; Thomsen K
    Curr Med Res Opin; 1973; 1(10):596-602. PubMed ID: 4778724
    [No Abstract]   [Full Text] [Related]  

  • 49. Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.
    Saletu B; Itil TM; Arat M; Akpinar S
    Int Pharmacopsychiatry; 1973; 8(4):193-207. PubMed ID: 4589638
    [No Abstract]   [Full Text] [Related]  

  • 50. Lorazepam in phobic disorders: a pilot study.
    Silverstone JT
    Curr Med Res Opin; 1973; 1(5):272-5. PubMed ID: 4589714
    [No Abstract]   [Full Text] [Related]  

  • 51. [Flupentixol (Fluanxol) or diazepam in the treatment of various psychosomatic conditions. A controlled double-blind multicenter study].
    Damsbo N; Lassen T; Falhof SL
    Ugeskr Laeger; 1986 Dec; 149(1):12-6. PubMed ID: 3544417
    [No Abstract]   [Full Text] [Related]  

  • 52. Maintenance therapy of chronic psychostic patients with a weekly oral dose of R 16 341. A controlled double-blind study.
    Baro F; Brugmans J; Dom R; Van Lommel R
    J Clin Pharmacol J New Drugs; 1970; 10(5):330-41. PubMed ID: 4917354
    [No Abstract]   [Full Text] [Related]  

  • 53. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients.
    Shopsin B; Pearson E; Gershon S; Collins P
    Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112
    [No Abstract]   [Full Text] [Related]  

  • 54. A controlled comparison of flupenthixol decanoate injections and oral amitriptyline in depressed out-patients.
    Tam W; Young JP; John G; Lader MH
    Br J Psychiatry; 1982 Mar; 140():287-91. PubMed ID: 7093597
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clorazepate (tranxene). Another benzodiazepine.
    Med Lett Drugs Ther; 1972 Nov; 14(23):85-6. PubMed ID: 4630756
    [No Abstract]   [Full Text] [Related]  

  • 56. Efficacy and tolerability of flupenthixol decanoate in the treatment of depression and psychosomatic disorders: a multicenter trial in general practice.
    Budde G
    Prog Neuropsychopharmacol Biol Psychiatry; 1992 Sep; 16(5):677-89. PubMed ID: 1496124
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of lorazepam as an anxiolytic agent in psychiatric practice.
    Lasich AJ
    S Afr Med J; 1974 Apr; 48(16):681-3. PubMed ID: 4823727
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical and EEG investigations with CI-579 and CI-600 (quantitative pharmacoelectroencephalography and "sleep prints").
    Itil TM; Saletu B; Gannon P; Arat M; Hsu W
    Behav Neuropsychiatry; 1973; 4-5(11-12, 1-6):61-8 passim. PubMed ID: 4583772
    [No Abstract]   [Full Text] [Related]  

  • 59. Lorazepam in the treatment of anxiety.
    Haider I
    Curr Med Res Opin; 1972; 1(2):70-3. PubMed ID: 4589020
    [No Abstract]   [Full Text] [Related]  

  • 60. Rational use of psychotropic drugs. III. Major tranquilizers.
    Greenblatt DJ; Shader RI
    Am J Hosp Pharm; 1974 Dec; 31(12):1226-31. PubMed ID: 4156455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.